4611 Chapter 13 PDF Lecture Slides
Chapter 13: Glucose Metabolism
Overview
Reading spans pages 366-393.
Learning Objectives
Glycolysis:
Purpose: Convert glucose to pyruvate, producing energy.
Location: Occurs in the cytosol of the cell.
Regulation: Involves various enzymes and intermediates.
Intermediates, cofactors, and enzymes to recall include:
Intermediates: Glucose, Glucose-6-phosphate (G6P), Fructose-6-phosphate (F6P), Fructose-1,6-bisphosphate (FBP), Dihydroxyacetone phosphate (DHAP), Glyceraldehyde-3-phosphate (GAP), 3-Phosphoglycerate (3PG), Phosphoenolpyruvate (PEP), Pyruvate.
Cofactors: ATP, ADP, NADH.
Enzymes: Hexokinase, phosphoglucose isomerase, phosphofructokinase, aldolase, triose phosphate isomerase, glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate kinase, phosphoglycerate mutase, enolase, pyruvate kinase.
Advantage of hexokinase phosphorylation: Prevents glucose from leaving the cell, maintaining a concentration gradient that favors import.
Mechanistic studies used evidence from alanine screening, transition state analogs, and radiolabels.
Fate of pyruvate:
Under aerobic conditions: Converted to acetyl-CoA.
Under anaerobic conditions in humans: Reduced to lactate.
Under anaerobic conditions in yeast: Converted to ethanol.
Glycolysis Overview
Glycolysis has two stages:
Stage 1: Glucose ➜ G-3-P (requires 2 ATP).
Stage 2: G-3-P ➜ Pyruvate (produces 4 ATP).
Net Yield: 2 ATP + 2 NADH.
Location: Cytosol.
Energy recovery depends on conditions:
Anaerobic: 2 NADH → heat.
Aerobic: 2 NADH → ~5 ATP.
Detailed Steps of Glycolysis
Step 1: Hexokinase
Mechanism makes the reaction irreversible.
Phosphorylation prevents glucose from leaving the cell.
Reduces intracellular glucose concentration.
Step 2: Phosphoglucose Isomerase (PGI)
Reaction is reversible; direction depends on concentrations.
Converts G6P to F6P.
Enzymatic Mechanisms
Phosphofructokinase-1 (PFK-1)
Phosphorylates F6P to FBP using ATP.
Reaction similar to hexokinase step.
Aldolase
Catalyzes the cleavage of FBP to GAP and DHAP.
Uses a Schiff base mechanism supported by alanine screening.
Triose Phosphate Isomerase (TIM)
Evidence for the enediolate intermediate in reaction mechanisms using transition state analogs.
Additional Steps
Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH)
Mechanism involves direct hydride transfer.
Evidence from enzyme inactivation and substrate binding.
Phosphoglycerate Kinase (PGK)
Involves a reaction similar to the reverse of the hexokinase reaction for ATP generation.
Enolase
Lyase that converts 2-phosphoglycerate to phosphoenolpyruvate (PEP) via dehydration.
Pyruvate Kinase
Generates ATP by converting PEP to pyruvate; regulated by energy state of the cell.
Fate of Pyruvate
Under anaerobic conditions in animals: Converted into lactate via lactate dehydrogenase, regenerating NAD+.
Under anaerobic conditions in yeast: Pyruvate decarboxylated to acetaldehyde, then reduced to ethanol.
Aerobic conditions: Converted to Acetyl-CoA or Oxaloacetate for further processes.
Gluconeogenesis
Mainly occurs in the liver; energetically expensive (4 ATP + 2 GTP required).
Involves bypass of irreversible glycolytic steps.
Glycogen Metabolism
Synthesis
Phosphoglucomutase converts G6P to G1P.
G1P is activated to UDP-glucose by UTP.
Glycogen synthase links glucose units.
Branch points created by glycogen-branching enzyme moving glucose residues.
Breakdown
Glycogen phosphorylase functions via phosphorolysis to produce G1P.
Debranching enzyme removes branches at α(1→6) links when 4 glucose residues are left.
Pentose Phosphate Pathway
Produces ribose for nucleotides and NADPH.
Pathways depend on the cell's need:
Oxidative: Irreversible, produces NADPH and ribulose-5-phosphate.
Carbon rearrangement: Reversible reactions producing ribose-5-phosphate or intermediates based on metabolic needs.
Cancer Metabolism
Cancer cells exhibit the Warburg effect: higher rates of glycolysis.
Targeting glycolytic pathways can provide treatment avenues for cancers.
Glycolytic Mechanisms in Cancer Diagnostics
Understanding glycolytic pathways aids in diagnostic imaging for cancers, exemplified through 6-phospho-FdG detection.